Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome

Completed · Phase 2/Phase 3

Conditions studied: Dry Eye Syndromes

In brief

The purpose of this study is to determine whether ecabet ophthalmic solution is an effective treatment for dry eye syndrome

Key facts

Study ID

NCT00198536

Run by

Bausch & Lomb Incorporated

People needed

159

Starts

2005-04-01

Expected to finish

2005-12-01

Last updated by the study team

2013-03-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Agree to avoid systemic \& topical ophthalmic meds \& disallowed meds
• Have a best corrected visual acuity (BCVA) of 20/40 with pinhole or better in each eye
• Diagnosis of moderate dry eye syndrome

You may not qualify if…

• Uncontrolled ocular or systemic disease that could interfere with study
• Diagnosis of Sjogren's syndrome, lacrimal obstruction, reflex, lid-related or contact lens-related dry eye syndrome(DES); significant anterior blepharitis or meibomianitis
• Contraindications or hypersensitivity to use of study meds or components
• Wear contact lenses
• Secondary dry eye to surgery
• Eye surgery (including laser) within 6 months
• Use of systemic or topical ophthalmic meds within 14 days
• Punctal plugs in one or both eyes in place for <45 days
• Permanent occlusion of the lacrimal puncta

Where it is running

• Central Maine Eye Care — Lewiston, Maine, United States
• Andover Eye Associates — Andover, Massachusetts, United States
• Eyesight Ophthalmic Services, PA — Dover, New Hampshire, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.